Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R21 Clinical Trial Optional)
This grant funds research on tobacco, alcohol, & cannabis policies in the US, focusing on how they affect use & exposure in disparity populations to promote health equity.
This grant is no longer accepting proposals
National Institutes of Health has archived this opportunity.
Funder: National Institutes of Health (NIH)
Due Dates: January 7, 2028 (Next due date)
Funding Amounts: Up to $200,000 total costs over 2 years typical for R21 exploratory/developmental projects.
Summary: Supports research on tobacco, alcohol, and cannabis policies in the U.S. focusing on their impact on use and exposure among disparity populations to promote health equity and cancer prevention.
Key Information: Community engagement with organizations is required; clinical trials are optional; broad eligibility including nonprofits, governments, academic institutions, and small businesses.
Description
This NIH funding opportunity supports exploratory and developmental research projects (R21 mechanism) that examine new or adapted policies related to tobacco, alcohol, and/or cannabis within the United States. The primary focus is on how these policies influence use or secondhand exposure among populations experiencing health disparities. The overarching goal is to promote health equity and cancer prevention by addressing disparities in tobacco, alcohol, and cannabis use and exposure.
Funded projects must involve authentic engagement with one or more community organizations to ensure that research efforts are aligned with equity goals. The program encourages innovative policy research that can inform effective interventions to reduce cancer risk and improve health outcomes in underserved populations.
This opportunity allows for clinical trials but does not require them (clinical trial optional). It is designed to support early-stage, exploratory studies that can lead to larger-scale research.
